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LETTERS TO THE EDITOR
Is Acute Rest Scintigraphic
Myocardial Perfusion
Imaging in Patients with
Acute Chest Pain and
Nondiagnostic Electrocardiograms
Clinically Useful, or Is It Misleading?
The study by Heller et al. is consistent with other studies
that have focused on chest pain patients with low coronary
event rates, demonstrating excellent negative predictive
accuracy (99%), but poor positive predictive accuracy (12%)
(1,2). In fact, the positive predictive value of the test is so
poor as to be misleading and may explain why the authors
had a 6% event rate but a 25% cardiac catheterization rate,
presumably prompted by the abnormal resting nuclear
scintigrams. This extremely poor positive predictive value
needs to be stressed, so that physicians contemplating using
nuclear studies in the management of chest pain patients use
another technique, such as exercise testing, for risk stratify-
ing patients who rule out for myocardial infarction but who
have an abnormal resting nuclear scan. Our institution uses
immediate exercise treadmill testing to evaluate chest pain
patients in the emergency department. Our negative pre-
dictive value is 100% and our positive predictive value is
50% (3–5). The authors concluded that nuclear scintigraphy
is cost effective, but a different conclusion might be reached
if the cost of the cardiac catheterizations for patients with
false positive scans was included in the cost analysis. I would
appreciate their input on this question.
William R. Lewis, MD
School of Medicine
Cardiovascular Medicine
4150 V Street, Suite 3500
Sacramento, California 95817
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REPLY
An important aspect of the design of our study (1) needs to
be emphasized: the physicians who managed the patients
after hospital admission were blinded toward the results of
resting myocardial perfusion imaging. Thus, subsequent
cardiac catheterization was definitely not “prompted” by
abnormal resting images. It would therefore be inappropri-
ate to incorporate the cost of cardiac catheterization in the
cost analysis. Cardiac catheterization was neither part of the
design of study, nor would it be appropriate to automatically
propose cardiac catheterization in all patients with abnormal
resting images.
The relatively low positive predictive value of 12% in our
study refers to the proportion of patients with abnormal
images who had transient CK and CK-MB enzyme eleva-
tions. It is known from previous studies that abnormal
resting myocardial perfusion images occur not only in
patients with acute myocardial infarction (1), but also in
patients with unstable angina (2–8). It is therefore incorrect
to assume that 78% of positive images were necessarily
falsely positive. In fact, these images likely visualized accu-
rately resting myocardial hypoperfusion in patients with chest
pain. This notion is supported by the subsequent clinical
course of these patients. The attending physicians decided
independently to refer more patients to cardiac catheteriza-
tion who had (unbeknownst to them) abnormal resting
images than patients who had normal images. Admittedly,
in some patients, true inferior myocardial perfusion defects
could not always be distinguished definitely from inferior
attenuation. The 50% positive predictive value mentioned
by Dr. Lewis presumably refers to the proportion of patients
with positive exercise tests in relation to angiographic
coronary artery disease. Thus, the positive predictive values
in our study and the one mentioned by Dr. Lewis, refer to
two different benchmarks: cardiac enzymes and angio-
graphic coronary artery disease.
In evaluating patients with acute chest pain and nondi-
agnostic electrocardiograms goal should be not only to
identify patients with acute myocardial infarction (which is
achieved by serial enzymes levels), but also to identify
patients with unstable ischemic syndromes. Myocardial
perfusion imaging serves very well for this purpose, as we
demonstrated in our study. The next goal then, is to identify
patients with significant chronic coronary artery disease.
We, and others, routinely perform early stress testing in the
emergency department once an acute ischemic syndrome
has been ruled out. However, in our experience a substantial
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percentage (;30%) of patients seen in the emergency
department with symptoms of chest pain cannot perform
adequate treadmill exercise. In these patients we perform
vasodilator myocardial perfusion imaging.
Our study examined the usefulness of resting myocardial
perfusion imaging alone for triaging patients with chest pain
and nondiagnostic electrocardiograms. We believe that
optimal protocols for evaluating patients with chest pain in
emergency department chest pain units should incorporate
combined discriminative use of biomarkers of cardiac injury,
radionuclide myocardial perfusion imaging, and stress test-
ing. There is a need for the development guidelines for
optimal use of various diagnostic resources for effective
management of low risk patients with chest pain syndromes
(9).
Frans J. Th. Wackers, MD
Cardiovascular Nuclear Imaging Laboratory
Yale University School of Medicine
New Haven, Connecticut
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Plasma Lipoprotein (a) and Severity of
Angiographic Coronary Artery Disease
A recent study published in your Journal by Schwartzman et
al. (1) in 129 white patients (43 women) undergoing
coronary angiography for chronic stable angina reported
significantly higher plasma Lp(a) levels in those patients
showing significant coronary artery disease stenoses. How-
ever, this difference failed to achieve statistical significance
in men and Lp(a) concentrations did not differ significantly
among patients with one-, two- and three-vessel disease.
A study based on a population of 132 men younger than
50-years old who were consecutively diagnosed with coro-
nary artery disease (angina or infarction) and underwent
coronary angiography was recently carried out by our group
in Spain. No patients received niacin or nicotinic acid
therapy. A vessel score according to the number of major
epicardial vessels was performed and coronary artery steno-
ses greater than 50% were considered as significant. Plasma
Lp(a) was measured using a commercially available ELISA
(Tint Elize Lp(a) strip-well format). Lp(a) data are ex-
pressed as median (5th and 95th percentiles) and the
statistical analysis was performed using the Kruskal-Wallis
test.
The results are summarized in the following Table 1:
In conclusion, our investigation in men less than 50-years
old who were hospitalized because an acute coronary syn-
drome showed significant higher Lp(a) levels according to
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0 13 12 (1.5–75)
1 49 27 (2.5–96) 0.003
2 42 34 (7–90)
3 28 63 (2–116)
590 Letters to the Editor JACC Vol. 33, No. 2, 1999
February 1999:589–92
